Cargando…

Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a severe complication of chronic hepatitis B virus (HBV) infection. HCC can still develop in CHB patients undergoing antiviral therapy. Although several scoring systems for the prediction of HCC risk in CHB patients are available, very few of them ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chih-Lang, Wu, Szu-Yuan, Lai, Ming-Wei, Hsu, Chao-Wei, Chen, Wan-Ming, Jao, An-Tzu, Chien, Cheng-Hung, Hu, Ching-Chih, Chien, Rong-Nan, Yeh, Chau-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340409/ https://www.ncbi.nlm.nih.gov/pubmed/37444453 http://dx.doi.org/10.3390/cancers15133343

Ejemplares similares

UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy
por: Liang, Kung-Hao, et al.
Publicado: (2016)

A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
por: Lin, Chih-Lang, et al.
Publicado: (2023)

The Defective Allele of Aldehyde Dehydrogenase 2 Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular Carcinoma
por: Huang, Po-Han, et al.
Publicado: (2019)

Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
por: Lee, I-Cheng, et al.
Publicado: (2022)

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
por: Lai, Ming-Wei, et al.
Publicado: (2019)

Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure
por: Lee, I-Cheng, et al.
Publicado: (2017)

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
por: Chen, Yen-Chun, et al.
Publicado: (2022)

The Protective Effect of Vitamin D on Dementia Risk in Hemodialysis Patients
por: Lin, Chih-Lang, et al.
Publicado: (2023)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Using Finite Element and Eigenmode Expansion Methods to Investigate the Periodic and Spectral Characteristic of Superstructure Fiber Bragg Gratings
por: He, Yue-Jing, et al.
Publicado: (2016)

Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
por: Chen, Yu-Syuan, et al.
Publicado: (2022)

Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections
por: Chao, Chien-Ming, et al.
Publicado: (2016)

Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy
por: Liu, Yuh-Ying, et al.
Publicado: (2022)

Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Short-Term Outcomes of Hip Fractures in Patients Aged 90 Years Old and Over Receiving Surgical Intervention
por: Lin, Wei-Ting, et al.
Publicado: (2015)

A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients
por: Huang, Ya-Hui, et al.
Publicado: (2017)

Association of Statin and Its Lipophilicity With Cardiovascular Events in Patients Receiving Chronic Dialysis
por: Wang, Shih‐Wei, et al.
Publicado: (2019)

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy
por: Hsu, Wei-Fan, et al.
Publicado: (2022)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
por: Chan, Kun-Ming, et al.
Publicado: (2023)

Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study
por: Hu, Ching-Chih, et al.
Publicado: (2015)

Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment
por: Chiu, Shao-Ming, et al.
Publicado: (2020)

An Occult Hepatitis B-Derived Hepatoma Cell Line Carrying Persistent Nuclear Viral DNA and Permissive for Exogenous Hepatitis B Virus Infection
por: Lin, Chih-Lang, et al.
Publicado: (2013)

Patients with Non-Alcoholic Fatty Liver Disease and Alcohol Dehydrogenase 1B/Aldehyde Dehydrogenase 2 Mutant Gene Have Higher Values of Serum Alanine Transaminase
por: Chien, Tsuo-Hsuan, et al.
Publicado: (2023)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study
por: Liang, Kung-Hao, et al.
Publicado: (2018)

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C
por: Lin, Sheng Feng, et al.
Publicado: (2020)

The Combination of Sleep Disorders and Depression Significantly Increases Cancer Risk: A Nationwide Large-Scale Population-Based Study
por: Hsu, Fang-Chin, et al.
Publicado: (2022)

The clinical outcomes of elderly esophageal cancer patients who received definitive chemoradiotherapy
por: Lu, Hao-Wei, et al.
Publicado: (2020)

Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs
por: Liang, Chih-Ming, et al.
Publicado: (2019)

Increased Glycated Hemoglobin but Decreased Cholesterol after a Loss of Helicobacter pylori Infection: A Community-Based Longitudinal Metabolic Parameters Follow-Up Study
por: Chen, Li-Wei, et al.
Publicado: (2021)

The influence of over-distraction on biomechanical response of cervical spine post anterior interbody fusion: a comprehensive finite element study
por: Cheng, Chih-Hsiu, et al.
Publicado: (2023)

Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
por: Liu, En-Shao, et al.
Publicado: (2021)

Emergence of Oncogenic‐Enhancing Hepatitis B Virus X Gene Mutants in Patients Receiving Suboptimal Entecavir Treatment
por: Lin, Chih‐Lang, et al.
Publicado: (2019)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

A community-based study on the association between Helicobacter pylori Infection and obesity
por: Chen, Li-Wei, et al.
Publicado: (2018)

Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
por: Huang, Yu-Ming, et al.
Publicado: (2022)

Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns
por: Huang, Yu-Han, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3m3tifj1fnntd8ihd2bhan6tjk